Company Quick10K Filing
Presbia
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
8-K 2019-04-22 Officers
8-K 2019-04-16 Enter Agreement, Exit Costs, Impairments, Officers
8-K 2019-04-03 Other Events
8-K 2019-02-01 Officers, Exhibits
8-K 2018-12-10 Enter Agreement, Off-BS Arrangement, Sale of Shares, Shareholder Rights, Exhibits
8-K 2018-11-19
8-K 2018-10-05 Other Events
8-K 2018-08-30 Officers, Shareholder Vote
8-K 2018-07-30 Regulation FD, Exhibits
8-K 2018-04-12 Enter Agreement, Sale of Shares, Shareholder Rights, Exhibits
8-K 2018-03-19 Officers
8-K 2018-02-16 Officers
8-K 2018-02-12 Exhibits
8-K 2018-01-22 Officers, Exhibits
8-K 2018-01-03 Exhibits

Presbia Financials

-

LENS Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Pavmed (PAVM) 38,577 7,060 8,940 0 0 -6,485 -5,093 31,669
Restoration Robotics (HAIR) 25,740 23,175 36,157 19,801 8,882 -30,382 -29,504 42,050
Retractable Technologies (RVP) 23,852 36,263 10,497 35,655 10,716 50 1,087 22,920
Dynatronics (DYNT) 14,310 39,632 18,876 62,565 19,174 -336 -1,740 14,358
Isoray (ISR) 28,303 9,422 1,742 5,390 3,047 -5,144 -5,144 22,796
Dariohealth (DRIO) 21,001 12,326 6,232 7,472 1,575 -19,804 -19,804 13,015
Biolase (BIOL) 33,040 32,362 28,570 42,952 16,456 -20,383 -19,229 44,008
Ra Medical Systems (RMED) 45,828 69,280 9,483 5,800 1,378 -34,418 -34,350 -9,301
Co-Diagnostics (CODX) 13,864 5,318 512 85 37 -6,302 -6,247 10,008
Lianluo Smart (LLIT) 21,368 5,699 2,582 0 0 0 0 20,891
Hancock Jaffe Laboratories (HJLI) 18,997 7,253 2,601 103 72 -6,770 -6,653 13,722
Alliqua Biomedical (ALQA) 17,714 2,703 11,954 937 -10 -7,586 -5,012 19,826
Cytori Therapeutics (CYTX) 92 8,884 15,160 2,983 230 -16,863 -13,050 6,335
Invivo Therapeutics Holdings (NVIV) 6,891 13,608 3,140 0 0 -11,479 -11,414 -3,121
Neurometrix (NURO) 5,087 10,814 5,957 5,478 3,604 -3,028 -3,028 128
Inspiremd (NSPR) 5,030 9,284 3,710 3,360 794 -9,637 -9,637 207
Presbia (LENS) 4,530 2,986 20 -31 -8,416 -8,408 -2,527
InfuSystem (INFU) 72,361 72,643 72,156 41,089 -1,373 9,251 31,860
Daxor (DXR) 31,097 85,725 49,508 0 0 0 0 31,038
Pro Dex (PDEX) 8,812 25,520 8,512 28,594 10,531 5,017 6,991 5,673

Balance Sheet ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash35,26329,80625,37121,74918,55914,64210,5277,33314,79710,6687,0603,2361,0523,3281,4282,527
Accounts Receivable443234116313350343101188231220
Inventory31440141943049451048530229324920412777716859
PP&E1,1081,1571,1591,1947437417721,3236896436131,3944484103881,142
Assets36,70131,60026,97823,40720,13416,55213,81510,37717,68313,6949,8365,5623,4345,6253,6404,530
Accounts Payable1,9651,6241,290736667471354399845466473628761471738605
Long-Term Debt
Liabilities2,7092,2302,0741,3821,4581,2172,1581,9382,8352,8573,1252,4312,5061,8551,7382,986
Stockholders' Equity33,99229,37024,90422,02518,67615,33511,6578,43914,84810,8376,7113,1319283,7701,9021,544
Income Statement ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Revenue734210283313-55-88133122
Cost of Revenue47143468212631202119125747121
Gross Profit2628-24-40-18-23-18-207-6-17-4-56-442101
R&D1,7762,5022,3331,3241,2941,2441,3101,6931,8422,0222,0661,144709974965882
SG&A2,8382,8412,5221,9842,4572,6142,9321,8502,7152,4652,6441,7341,2141,2541,4991,027
Tax549126364162520184375-215-63
Net Income-4,593-5,319-4,900-3,349-3,765-3,882-4,259-3,850-4,593-4,533-4,740-3,132-2,013-2,251-2,250-1,902
Cash Flow ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash Operating-1,801-1,677
Cash Investing0-2
Cash Financing-1042,777